Related Experiment Video
Updated: Jun 25, 2026

Assessment of Respiratory Function in Conscious Mice by Double-chamber Plethysmography
Published on: July 10, 2018
Comparison of the effects of low-dose vs. high-dose aminophylline on lung function in experimental meconium
1Department of Physiology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovakia. mokra@jfmed.uniba.sk
Abstract:
Due to missing information on appropriate dosing of aminophylline in meconium aspiration syndrome (MAS), this study compared effects of high-dose and low-dose aminophylline on lung function of animals with MAS. Meconium-instilled rabbits were treated by low-dose (LD, 1.0 mg/kg), or high-dose (HD, 2.0 mg/kg) aminophylline at 0.5 and 2.5 h after meconium instillation, or were left untreated. Within 5 h of oxygen ventilation, HD-aminophylline improved gas exchange, reduced pulmonary shunts and ventilatory pressures, and decreased edema formation and lung neutrophils. LD-aminophylline enhanced lung function to a lower extent than HD-aminophylline, and failed to reduce lung edema and the number of lung neutrophils. Both treatments decreased lung peroxidation, with a stronger effect of HD-aminophylline on lipid oxidation and of LD-aminophylline on protein oxidation. Tracheal reactivity to histamine decreased after HD-aminophylline, while lung tissue reactivity was more reduced after LD-aminophylline. Although LD-aminophylline showed some anti-inflammatory potential, HD-aminophylline improved most of the parameters more effectively.
Insights
High-dose aminophylline significantly improved lung function in meconium aspiration syndrome (MAS) models, outperforming low-dose treatments. This suggests higher doses are more effective for treating MAS-related respiratory distress.
Area of Science:
- Neonatal Medicine
- Pulmonary Pharmacology
- Respiratory Physiology
Background:
- Meconium aspiration syndrome (MAS) poses significant risks to newborns, often requiring respiratory support.
- Optimal therapeutic strategies, particularly aminophylline dosing, remain under-investigated in MAS.
- Existing research lacks clear guidelines on aminophylline's efficacy in MAS treatment.
Purpose of the Study:
- To compare the effects of high-dose (HD) versus low-dose (LD) aminophylline on lung function in a rabbit model of MAS.
- To evaluate aminophylline's impact on gas exchange, pulmonary hemodynamics, inflammation, and oxidative stress in MAS.
- To determine the optimal dosage of aminophylline for managing MAS complications.
Main Methods:
- MAS was induced in rabbits via meconium instillation.
- Animals received either HD (2.0 mg/kg) or LD (1.0 mg/kg) aminophylline at 0.5 and 2.5 hours post-instillation, or served as untreated controls.
- Lung function parameters, including gas exchange, ventilatory pressures, edema, neutrophils, peroxidation, and tracheal reactivity, were assessed within 5 hours of ventilation.
Main Results:
- HD-aminophylline significantly improved gas exchange, reduced pulmonary shunts, ventilatory pressures, edema, and lung neutrophils compared to controls.
- LD-aminophylline showed some lung function improvement but was less effective than HD-aminophylline, failing to reduce edema or neutrophils.
- Both doses reduced lung peroxidation, with HD-aminophylline showing a stronger effect on lipid oxidation and LD-aminophylline on protein oxidation. Tracheal reactivity decreased with both treatments, more so in lung tissue with LD-aminophylline.
Conclusions:
- High-dose aminophylline demonstrates superior efficacy in improving lung function and mitigating key pathological features of MAS compared to low-dose administration.
- While LD-aminophylline exhibits some anti-inflammatory effects, HD-aminophylline provides more comprehensive benefits in managing MAS.
- Further clinical investigation into HD-aminophylline for MAS treatment is warranted based on these findings.
Related Concept Videos
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
